Merit Medical projects 2023 revenue of $1.255B-$1.259B, up 9.0%-9.4% YoY

MERIT MEDICAL SYSTEMS INC

Preliminary unaudited revenue for FY2023: $1.255B-$1.259B, 9.0%-9.4% growth over FY2022.
Constant currency revenue growth estimated at 9.6%-9.9% for FY2023.
Full Q4 and FY2023 results and FY2024 guidance will be issued on February 28, 2024.
Revenue figures are preliminary and subject to completion of year-end close and audit.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

MERIT MEDICAL SYSTEMS INC reported year ended December 31, 2023 results: revenue $1.255 billion - $1.259 billion.

Period: year ended December 31, 2023
Revenue: $1.255 billion - $1.259 billion
Result: preliminary results

Exact text from the filing

FOURTH QUARTER AND YEAR END 2023 RESULTS AND ISSUE FISCAL YEAR 2024 GUIDANCE ON FEBRUARY 28, 2024 ● 2023 reported preliminary unaudited revenue in the range of approximately $1.255 billion - $1.259 billion, up approximately 9.0% - 9.4% year-over-year ● 2023 preliminary unaudited constant currency revenue* in the range of up approximately 9.6% - 9.9% year over year

View on SEC.gov

Browse all earnings releases →

MERIT MEDICAL SYSTEMS INC filing history →

Source: SEC EDGAR

accession 0000856982-24-000004

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.